2016
DOI: 10.12968/hmed.2016.77.2.90
|View full text |Cite
|
Sign up to set email alerts
|

Liver biopsy: past, present and future

Abstract: Liver biopsy is an integral part of evaluation of liver disease. Indications and techniques have developed to allow functional and prognostic liver assessment, along with biochemistry and dynamic imaging, in both diffuse and focal liver disease. However, non-invasive techniques are changing the way clinicians use liver biopsy.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
12
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 11 publications
(12 citation statements)
references
References 29 publications
0
12
0
Order By: Relevance
“…Histopathologic examination of liver biopsy tissue remains the reference standard for staging hepatic fibrosis. However, liver biopsy has a number of limitations, including invasiveness,(Actis et al 2007) (Ravindran et al 2016) high cost, inter-pathologist variation (Burt et al 2015; Kaswala et al 2016) and sampling error (Brunt 2016; Parikh et al 2017; Shiha et al 2017). As a result, alternative non-invasive staging methods have been proposed including blood tests (Chin et al 2016; Rosenberg et al 2004), magnetic resonance elastography (MRE)(Dulai et al 2016; Petitclerc et al 2017), and ultrasound elastography (UE)(Crespo et al 2012; Dhyani et al 2015; Sigrist et al 2017).…”
Section: Introductionmentioning
confidence: 99%
“…Histopathologic examination of liver biopsy tissue remains the reference standard for staging hepatic fibrosis. However, liver biopsy has a number of limitations, including invasiveness,(Actis et al 2007) (Ravindran et al 2016) high cost, inter-pathologist variation (Burt et al 2015; Kaswala et al 2016) and sampling error (Brunt 2016; Parikh et al 2017; Shiha et al 2017). As a result, alternative non-invasive staging methods have been proposed including blood tests (Chin et al 2016; Rosenberg et al 2004), magnetic resonance elastography (MRE)(Dulai et al 2016; Petitclerc et al 2017), and ultrasound elastography (UE)(Crespo et al 2012; Dhyani et al 2015; Sigrist et al 2017).…”
Section: Introductionmentioning
confidence: 99%
“…However, these imaging strategies are limited, as structural changes often occur relatively late in the course of a disease. Although liver biopsy is still considered the gold standard for diagnosis and staging of diffuse chronic liver diseases (CLDs) (2), it has several major limitations, including its invasive nature, high cost, poor patient acceptance, and sampling error . Furthermore, the accurate histological evaluation of liver biopsy specimens requires experienced, sub‐specialized pathologists.…”
mentioning
confidence: 99%
“…Even so, it may be subjective, and is prone to relatively low inter‐observer agreement . These drawbacks may challenge the role of liver biopsy for monitoring disease progression, therapy response assessment, and longitudinal follow‐up studies . Blood markers of parenchymal liver disease are a noninvasive diagnostic alternative to liver biopsy, as they are easily obtained, are unaffected by sampling error, and can be repeated serially.…”
mentioning
confidence: 99%
“…as a result, there is strong desire for the application of more sensitive and acceptable techniques for early detection and diagnosis of aFL [4]. although liver biopsy is useful as the golden standard for diagnosis of aFL, the technique is greatly limited because of its nondynamic characterization and invasiveness, which potentially causes issues, such as organ trauma, infection, and bleeding [25]. in contrast, a noninvasive technique is more suitable for assessment of temporal changes of aFL in terms of patient' compliance.…”
Section: Discussionmentioning
confidence: 99%